Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NoZone is a medical technology company that develops ozone-free UV-C disinfection systems designed for clinical and healthcare environments. Founded by researchers from the University of Arizona, the company's technology provides a rapid and safe method for decontaminating medical devices, personal protective equipment (PPE), and high-touch surfaces without producing harmful ozone byproducts. NoZone's flagship products are engineered to be portable and user-friendly, aiming to reduce the transmission of pathogens and the incidence of healthcare-associated infections (HAIs). The company's proprietary technology was particularly highlighted during the COVID-19 pandemic for its ability to safely disinfect N95 masks for reuse. NoZone was recognized as a winner of the Flinn Foundation Bioscience Entrepreneurship Program, reflecting its potential impact on the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NoZone.